HAZNEDAROGLU, I. C. MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML). Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 6, n. 1, p. e2014009, 2013. DOI: 10.4084/mjhid.2014.009. Disponível em: https://www.mjhid.org/index.php/mjhid/article/view/2014.009. Acesso em: 28 jan. 2022.